Other studies have demonstrated OCT-1 enrichment in the target OCT-1 sites in breast cancer and other malignant tumors, OCT-1 being also a cancer stem cell determinant [15,16,17,18,19,20,21,22,23,24]. This evidence concerns the gene POU2F1 and breast carcinoma.